Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer [NA]
This trial update describes the effects of zinc supplementation on quality of life in patients with gastrointestinal cancers. The study has …
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Evaluation of Postoperative Ascites After Somatostatin Infusion Following Hepatectomy for Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial evaluating whether somatostatin infusion after hepatectomy reduces postoperative ascites in hepatocellular carcinoma.…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: Evaluation Of The Influence Of Anesthetic Interventions On The Evolution Of Hepatic Neoplastic Processes [NA]
A completed clinical trial assessing how anesthetic interventions, including lidocaine infusion, affect the progression of hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab [Phase 2]
Phase II study of nivolumab plus ipilimumab in advanced hepatocellular carcinoma patients who progressed on first-line atezolizumab plus bev…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Trajectory-Based Prognostic Modeling in Hepatocellular Carcinoma
A completed clinical trial evaluating trajectory-based prognostic modeling for hepatocellular carcinoma. The update notes the study is finis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Brazilian Reality of Hepatocellular Carcinoma
AstraZeneca-sponsored hepatocellular carcinoma trial conducted in Brazil has completed, with analyses by BCLC stage.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC [Phase 2]
A Phase 2 trial comparing locoregional therapy versus systemic therapy for intermediate-stage hepatocellular carcinoma (BCLC stage B) has be…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista [Phase 3]
Phase 3 study evaluating the safety and efficacy of atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma not previously tr…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Adjuvant Radiotherapy of Sintilimab Versus TACE for HCC [Phase 3]
Phase 3 clinical trial evaluating adjuvant radiotherapy with sintilimab versus transarterial chemoembolization for hepatocellular carcinoma …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: EchoTip AcuCore Post-Market Clinical Study
Completed post-market clinical study update for the EchoTip AcuCore device, detailing the completion of the post-market evaluation.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: JS014 Combined With Toripalimab and TACE in Unresectable HCC: a Phase Ib Study [Phase 1]
Phase Ib study evaluating JS014 in combination with toripalimab and transarterial chemoembolization (TACE) for unresectable hepatocellular c…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Individualized Dosimetry for Holmium-166 Radioembolization in Patients With Unresectable Hepatocellular Carcinoma [NA]
An Imperial College London-sponsored clinical trial evaluating individualized dosimetry for Holmium-166 radioembolization in unresectable he…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Real-world Study of Lenalidomide After First-line Treatment Lenvatinib With PD-1 in Advanced HCC [NA]
This entry notes a completed real-world trial evaluating lenalidomide after first-line treatment with lenvatinib and a PD-1 inhibitor in adv…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with a multi-kinase inhibitor for unresectable, locally advanced, or metastati…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures [NA]
Clinical trial update reports termination of the BioTraceIO 360 study for planning, monitoring, and assessment of liver tissue ablation proc…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment [Phase 2]
This Phase 2 trial evaluated colchicine for palliative treatment of primary hepatic malignant tumors in patients ineligible for curative tre…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients
ThinkRadial is a prospective study evaluating transradial deTACE in hepatocellular carcinoma. The study status on ClinicalTrials.gov is comp…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) [Phase 1]
A Phase 1 trial (ARYA-1) evaluating ET140203 T Cells in adults with advanced hepatocellular carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy
This clinical trial update discusses predictive biomarkers in adults with advanced hepatocellular carcinoma treated with systemic therapy; t…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: AI Multitask Model for HCC Treatment
A clinical trial evaluating an AI multitask model for hepatocellular carcinoma treatment has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer [Phase 2]
A Phase 2 trial evaluating the combination of sorafenib with hydroxychloroquine for hepatocellular carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer [Phase 2]
A Phase 2 study evaluating the combination of regorafenib and durvalumab for high-risk hepatocellular carcinoma is currently active but not …
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy [Phase 2]
Phase 2 trial of cabozantinib for hepatocellular carcinoma progressing after first-line immuno-oncology therapy; study status is not yet rec…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: A Pilot Study to Evaluate the Safety of a 3 Weeks Sitagliptin Treatment in HCC Patients Undergoing Liver Resection [Phase 1]
A Phase 1 pilot study assessing the safety of a 3-week sitagliptin treatment in patients with hepatocellular carcinoma undergoing liver rese…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: The Safety and Efficacy of Transarterial Chemoembolization (TACE) + Lenvatinib + Programmed Cell Death Protein 1 (PD-1) Antibody of Advanced Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and efficacy of transarterial chemoembolization combined with lenvatinib and a PD-1 antibody in advanced un…